Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PAIP2B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | EIF2S3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | NOB1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | PRMT5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | MVB12B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | GIMAP6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | NEDD8 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | EML5 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
mRNA | ORC3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | RPF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |